Athens Medical C.S.A. (IATR) — Capital Reinvestment Ratio
Athens Medical C.S.A. (IATR) has a Capital Reinvestment Ratio of 1.64x as of June 2023, meaning it reinvests 2% of its operating cash flow (€3.17 Million) in capital expenditures (€5.19 Million). Check Athens Medical C.S.A. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Athens Medical C.S.A. Capital Reinvestment Ratio (2014–2024)
This chart tracks Athens Medical C.S.A.'s Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Athens Medical C.S.A. operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Athens Medical C.S.A. (2014–2024)
Year-by-year Capital Reinvestment Ratio for Athens Medical C.S.A. from 2014 to 2024. See IATR free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.57x | €46.44 Million | €26.63 Million | ▼ -33.0% |
| 2023 | 0.86x | €26.13 Million | €22.35 Million | ▼ -99.3% |
| 2022 | 128.02x | €124.00K | €15.87 Million | ▲ +17767.6% |
| 2021 | 0.72x | €15.75 Million | €11.28 Million | ▲ +307.0% |
| 2020 | 0.18x | €40.21 Million | €7.08 Million | ▼ -65.9% |
| 2019 | 0.52x | €31.50 Million | €16.27 Million | ▲ +29.9% |
| 2018 | 0.40x | €20.02 Million | €7.96 Million | ▲ +3.1% |
| 2016 | 0.39x | €9.78 Million | €3.77 Million | ▲ +147.2% |
| 2015 | 0.16x | €12.89 Million | €2.01 Million | ▼ -81.4% |
| 2014 | 0.84x | €3.58 Million | €3.00 Million | — |